Deberah, a patient diagnosed with rheumatoid arthritis, osteoarthritis, and fibromyalgia, describes how these conditions impacted her daily life. She experienced pain, difficulty with hand function, and increasing challenges performing routine activities like opening jars and gardening. Seeking alternatives, she researched stem cell therapy and decided to pursue treatment at the Stem Cell Institute.
Her first stem cell treatment was in 2021, followed by additional treatments in 2022 and 2024. Deberah reports experiencing cognitive improvements in addition to physical relief, stating that the therapy made her brain feel more “alive” and helped with memory and overall mental clarity. Her primary goal with continued treatments is to maintain her progress and prevent the return of severe pain.
While Deberah describes her experience as positive, stem cell therapy remains an evolving area of research in managing autoimmune and degenerative conditions. Clinical studies have explored the role of mesenchymal stem cells (MSCs) in reducing inflammation and supporting tissue repair.
